Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance. 2005

Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
Department of Experimental Psychology, University of Cambridge, Downing Street, Cambridge, UK. jwd20@cam.ac.uk

Characterizing the nature and severity of cognitive deficits associated with chronic stimulant abuse may provide new insights into the neural substrates of drug addiction because such deficits may contribute to the chronic relapsing nature of compulsive drug use. This investigation examines in rats the long-term cognitive consequences of intravenously self-administered amphetamine, specifically on performance of a 5-choice serial reaction time task (5-CSRTT), which assesses visuo-spatial attention and impulsivity. Rats experienced 5 days of intravenous (i.v.) amphetamine self-administration and were then withdrawn for a period of 9 days, during which time testing on the 5-CSRTT took place. This was repeated on five consecutive occasions for a period of 10 weeks. Controls experienced identical training on the 5-CSRTT but during the self-administration sessions received yoked i.v. infusions of normal saline. The results reveal a selective and reproducible pattern of deficits on the 5-CSRTT following repeated withdrawal from amphetamine self-administration, with deleterious effects on the speed and accuracy of responding as well as increased omission errors. Premature (impulsive) responding, perseveration, and food consumption latencies were not significantly affected. Deficits in attentional performance fully recovered 4-5 days after amphetamine cessation and there was no evidence of any long-term disturbances, even when the attentional load was increased. However, following a 2-month abstinence period, abnormalities in the subsequent effects of acute noncontingent amphetamine were found, with increased omissions, slower response times, and reduced impulsivity. Thus, contingent i.v. amphetamine administration has both short- and long-term consequences, which may be relevant to the complex disturbances that accompany drug addiction.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D002755 Choice Behavior The act of making a selection among two or more alternatives, usually after a period of deliberation. Approach Behavior,Approach Behaviors,Behavior, Approach,Behavior, Choice,Behaviors, Approach,Behaviors, Choice,Choice Behaviors
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001288 Attention Focusing on certain aspects of current experience to the exclusion of others. It is the act of heeding or taking notice or concentrating. Focus of Attention,Selective Attention,Social Attention,Attention Focus,Attention, Selective,Attention, Social,Selective Attentions
D012646 Self Administration Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal. Administration, Self,Administrations, Self,Self Administrations

Related Publications

Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
October 2004, Psychopharmacology,
Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
June 1998, Psychopharmacology,
Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
February 1993, Pharmacology, biochemistry, and behavior,
Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
January 1987, NIDA research monograph,
Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
May 2004, Behavioural pharmacology,
Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
May 2001, Psychopharmacology,
Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
December 2008, Behavioural pharmacology,
Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
January 1989, NIDA research monograph,
Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
January 1975, Pharmacology, biochemistry, and behavior,
Jeffrey W Dalley, and David E H Theobald, and David Berry, and Jean A Milstein, and Kristjan Lääne, and Barry J Everitt, and Trevor W Robbins
October 2006, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!